High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical OptimizationPRNewsWire • 03/13/24
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 03/12/24
Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High CholesterolGlobeNewsWire • 03/11/24
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.The Motley Fool • 03/09/24
EYLEA® HD (aflibercept) Injection 8 mg Pivotal Data in Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) Published in The LancetGlobeNewsWire • 03/08/24
Regeneron Pharmaceuticals, Inc. (REGN) TD Cowen 44th Annual Health Care Conference Call TranscriptSeeking Alpha • 03/06/24
GENESIS Pharma Announces an Exclusive Distribution Agreement With Regeneron Pharmaceuticals to Commercialize cemiplimab in Greece, Cyprus and MaltaBusiness Wire • 03/01/24
Press Release: Dupixent® sBLA accepted for FDA Priority Review for treatment of COPD with type 2 inflammationGlobeNewsWire • 02/23/24
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 InflammationGlobeNewsWire • 02/23/24
Linvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority ReviewGlobeNewsWire • 02/21/24
Press Release: Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)GlobeNewsWire • 02/16/24
Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)GlobeNewsWire • 02/16/24
Regeneron Pharmaceuticals, Inc. (REGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)Seeking Alpha • 02/14/24
Regeneron Pharmaceuticals: Time To Change My Strategy After Encouraging Q4 2024Seeking Alpha • 02/10/24
The Surprising Sources Of Regeneron's Fourth-Quarter Beat As Shares Hit Another Record HighInvestors Business Daily • 02/02/24